Welcome to the most comprehensive PepGuide and peptide guide reference available for independent researchers, biohackers, and health optimization professionals. Whether you are just beginning to explore the science of research peptides or you are an experienced investigator looking to refine your protocols, this complete peptide reference handbook is designed to serve as your definitive starting point. Inside, you will find structured, evidence-based coverage of peptide classification, mechanism of action, reconstitution protocols, dosing considerations, stacking strategies, vendor quality assessment, and the legal landscape surrounding research compounds. Every section is built to give you clarity, precision, and confidence as you navigate one of the most dynamic areas of contemporary biochemical research.
1. PepGuide Fundamentals: Peptide Classification and Structural Taxonomy
Peptides are short chains of amino acids linked by peptide bonds. They occupy a unique position in biochemistry, sitting between small-molecule drugs and large biologics. From a structural taxonomy perspective, research peptides are generally classified by their amino acid chain length, receptor targets, and primary biological activity. Dipeptides contain two amino acids, while oligopeptides typically contain between three and twenty. Polypeptides extend beyond that range and begin to approach the complexity of proteins.
For the purposes of this peptide guide reference, the most relevant categories include growth hormone secretagogues, tissue repair peptides, cognitive and nootropic peptides, metabolic peptides, and longevity-focused compounds. Each category operates through distinct receptor binding and signal transduction pathways, which directly informs how researchers design their protocols. Understanding structural classification also helps explain why certain peptides require specific storage conditions, why some are orally inactive, and why molecular modifications such as DAC (Drug Affinity Complex) attachments can dramatically alter half-life and bioavailability.
2. How Research Peptides Work: Mechanism of Action and Receptor Binding
The mechanism of action for any given research peptide is determined by which receptors it binds to and what downstream signaling cascades it initiates. Receptor binding is selective, meaning that a peptide designed to activate growth hormone releasing hormone receptors will have a fundamentally different physiological profile than one designed to bind ghrelin receptors, even if both ultimately influence growth hormone output.
Signal transduction pathways translate receptor activation into cellular responses. For example, when a growth hormone secretagogue binds to the ghrelin receptor (GHSR-1a), it activates a G-protein coupled cascade that stimulates the pituitary to release growth hormone in a pulsatile fashion. This pulsatile release pattern is clinically important because it mimics natural physiological rhythms and reduces the risk of receptor desensitization. Understanding these pathways is central to this complete peptide reference and forms the backbone of intelligent research design. A useful overview of peptide receptor pharmacology is available through the National Center for Biotechnology Information's signal transduction resources.
3. The GHRH and GHRP Axis: Growth Hormone Secretagogue Pathways
One of the most thoroughly researched areas in peptide science involves the GHRH/GHRP axis. Growth Hormone Releasing Hormone (GHRH) peptides and Growth Hormone Releasing Peptides (GHRPs) work through complementary but distinct mechanisms, and understanding this distinction is essential for any serious peptide guide reference.
GHRH peptides, such as CJC-1295, act directly on the GHRH receptor in the pituitary gland. CJC-1295 is a synthetic analog of endogenous GHRH that has been modified to resist enzymatic degradation, extending its half-life significantly compared to native GHRH. When used with the DAC modification, CJC-1295 can bind to albumin in the bloodstream, extending its active window to several days. This longer duration supports a sustained elevation in growth hormone pulse amplitude rather than a single acute spike.
GHRPs, by contrast, work primarily through the ghrelin receptor. Ipamorelin is one of the most selectively studied GHRPs because it stimulates growth hormone release with minimal effect on cortisol or prolactin, making it a preferred choice for research stacks where side effect minimization is a priority. The combination of a GHRH analog like CJC-1295 with a GHRP like Ipamorelin represents a well-documented Ipamorelin stack approach in the research literature. The two compounds act synergistically: GHRH amplifies the growth hormone pulse while GHRP triggers its release, producing a combined effect greater than either compound alone.
This axis also connects to broader hormonal interactions. Somatostatin, the natural inhibitor of growth hormone release, can blunt the effects of GHRPs when somatostatin tone is elevated. This is why timing protocols, particularly dosing in a fasted state or before sleep when somatostatin is naturally lower, can meaningfully influence research outcomes. References to the GnRH (Gonadotropin-releasing hormone) reference class are also instructive here, as GnRH operates through a similar pulsatile release model and illustrates the broader principle that hormonal axis interactions require careful consideration in peptide research design.
4. Tissue Repair and Regenerative Peptides: BPC-157 and TB-500
Among all categories in this peptide guide reference, tissue repair peptides attract some of the most active interest from both clinical researchers and biohackers. Two compounds dominate this space: BPC-157 and TB-500.
BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide derived from a protein found in gastric juice. Its association with tissue regeneration is supported by a substantial body of preclinical research demonstrating accelerated healing of tendons, ligaments, muscle, nerve tissue, and gastrointestinal mucosa. The proposed mechanisms behind BPC-157 involve upregulation of growth factor signaling, promotion of angiogenesis (new blood vessel formation), and modulation of nitric oxide pathways. Notably, BPC-157 appears to be systemically active regardless of administration route, which has made both oral and injectable forms subjects of active investigation.
TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring peptide found in high concentrations at sites of tissue injury. TB-500 promotes actin polymerization, a critical step in cell migration and wound healing. It also exhibits anti-inflammatory properties and has been studied for its potential role in cardiac tissue repair and angiogenesis. Because TB-500 acts through a different mechanism than BPC-157, combining the two in a research stack is a common protocol for researchers investigating accelerated musculoskeletal recovery. The complementary actions of these two compounds on tissue repair pathways represent a compelling case study in synergistic peptide stacking.
5. Cognitive and Nootropic Peptides: Selank and Neuroprotective Research
The intersection of peptide science and cognitive enhancement is one of the most exciting frontiers in this complete peptide reference. Cognitive peptides generally work by modulating neurotransmitter systems, reducing neuroinflammation, promoting neurogenesis, or protecting existing neural tissue from oxidative and excitotoxic damage.
Selank is a synthetic heptapeptide developed from the endogenous tetrapeptide tuftsin. It was originally developed in Russia and has been extensively studied for its anxiolytic and nootropic properties. Selank neuroprotection research suggests it modulates BDNF (Brain-Derived Neurotrophic Factor) expression and influences serotonergic and dopaminergic tone without the sedating side effects associated with classical anxiolytics. Cognitive peptides like Selank are of particular interest to researchers studying stress resilience, memory consolidation, and mood regulation at a neurochemical level.
Other peptides relevant to neuroprotective research include Semax, a synthetic analog of ACTH with documented effects on BDNF and NGF (Nerve Growth Factor) expression, and Dihexa, an angiotensin-derived peptide with proposed synaptogenic effects. Researchers interested in cognitive enhancement consistently return to cognitive peptides as a category because the blood-brain barrier accessibility of these smaller peptides, combined with their receptor specificity, offers a degree of mechanistic precision that larger biologics cannot match.
6. Metabolic Peptides and Fat Loss Research: Semaglutide and Beyond
Metabolic optimization is another major pillar of this peptide guide reference. The most prominent compound in this space is Semaglutide, a GLP-1 receptor agonist that has transformed the clinical conversation around obesity and metabolic syndrome. As a research compound, Semaglutide mimics the action of glucagon-like peptide-1, a gut-derived hormone that regulates insulin secretion, gastric emptying, and appetite signaling through hypothalamic pathways.
Semaglutide's extended half-life, approximately one week, allows for once-weekly dosing protocols in clinical settings. In research contexts, its potent effects on appetite suppression and glucose homeostasis make it a focal point for studies on fat loss and metabolic optimization. Other GLP-1 analogs, as well as peptides like AOD-9604 (a fragment of the growth hormone molecule), are also studied for their selective lipolytic effects without the broader anabolic actions of full-length growth hormone.
IGF-1 LR3 (Insulin-like Growth Factor 1 Long R3) is another metabolically significant compound in this complete peptide reference. It is a modified form of IGF-1 engineered to have a significantly longer half-life than native IGF-1, approximately 20 to 30 hours compared to just a few hours for the native form. IGF-1 LR3 promotes protein synthesis, glucose uptake in muscle tissue, and lipolysis in adipose tissue. Its role in nutrient partitioning makes it a subject of intense research interest among investigators studying body composition and anabolic signaling pathways.
7. Complete Peptide Reference Guide to Reconstitution and Storage
Proper reconstitution and storage are foundational skills for any researcher using this PepGuide. Lyophilized (freeze-dried) peptides are the standard commercial form because they offer superior stability at room temperature during shipping. However, once reconstituted in bacteriostatic water or sterile water, peptides become significantly more vulnerable to degradation through hydrolysis, oxidation, and microbial contamination.
Bacteriostatic water is the preferred reconstitution medium for most research peptides because it contains 0.9% benzyl alcohol, which inhibits microbial growth and extends the usable life of a reconstituted vial to approximately four to six weeks when refrigerated at 2 to 8 degrees Celsius. Sterile water is appropriate for single-use applications but does not provide the same antimicrobial protection. Acetic acid solutions (0.1% to 1%) are preferred for certain peptides, particularly IGF-1 and its analogs, because these compounds are more soluble and stable in a mildly acidic environment.
When reconstituting a lyophilized peptide, researchers should inject the reconstitution solvent slowly down the inside wall of the vial rather than directly onto the peptide cake. Agitation, including vortexing, should be avoided because the mechanical shear forces can disrupt the delicate tertiary structure of some peptides. Gentle swirling until the solution clears is the recommended technique. Reconstituted vials should be stored in the dark, as ultraviolet light exposure accelerates oxidative degradation. Long-term storage of unreconstituted lyophilized peptides is best achieved at minus 20 degrees Celsius or colder, where most research peptides remain stable for one to two years when properly sealed.
8. Dosing Frameworks and Research Protocol Design
One of the most frequently referenced sections of any peptide guide is dosing. It is important to note at the outset that all dosing information presented in this PepGuide is intended strictly for in vitro and preclinical research contexts. Dosing parameters in published preclinical literature vary considerably depending on the animal model used, the route of administration, and the specific outcome being measured.
For growth hormone secretagogue research, published preclinical studies typically examine CJC-1295 at microgram-per-kilogram doses administered subcutaneously. The synergistic effects observed with combined GHRH/GHRP protocols in rodent models have informed many of the stacking frameworks discussed in the research community. Tissue repair peptides such as BPC-157 have been studied across a wide dose range in rodent models, with many published studies examining doses in the microgram range administered intraperitoneally or subcutaneously.
Frequency of administration is as important as dose magnitude. Pulsatile compounds like GHRPs are generally studied using multiple daily administrations to replicate the natural episodic release pattern of growth hormone. Longer-acting compounds like CJC-1295 with DAC or Semaglutide are studied with less frequent administration intervals. Researchers should always anchor their protocol design in the published literature for the specific compound and model system they are investigating, using this complete peptide reference as an organizational framework rather than a substitute for primary source review.
9. Peptide Stacking Strategies: Synergy, Timing, and Protocol Design
Stacking refers to the concurrent or sequentially timed use of two or more peptide compounds within a single research protocol. The rationale for stacking is rooted in receptor pharmacology: when two compounds act on distinct but complementary pathways, their combined effect can exceed what either compound produces independently. This PepGuide covers the most evidence-supported stacking combinations observed in preclinical research.
The CJC-1295 and Ipamorelin stack is the most widely cited growth hormone secretagogue combination in the research literature. As described earlier in this peptide guide, CJC-1295 amplifies the amplitude of growth hormone pulses via the GHRH receptor while Ipamorelin triggers release via the ghrelin receptor. Administering both compounds in close temporal proximity, typically within the same injection or within minutes of each other, maximizes the synergistic pulse output observed in preclinical models.
The BPC-157 and TB-500 combination is the dominant stack in tissue repair research. BPC-157 contributes its effects on angiogenesis and growth factor upregulation while TB-500 provides its actin-mediated cell migration and anti-inflammatory activity. Some researchers also incorporate a GH secretagogue stack alongside this repair combination to leverage the tissue-building effects of elevated growth hormone, creating a three-compound protocol with mechanistically distinct but complementary targets.
In metabolic research, AOD-9604 is sometimes studied alongside GLP-1 analogs for additive effects on lipolysis. The different mechanisms involved, selective GH fragment activity for AOD-9604 versus incretin-axis modulation for GLP-1 analogs, provide a rational basis for combination research. Researchers designing stacking protocols should carefully consider potential overlapping receptor targets, shared downstream pathways, and the logistical complexity that comes with managing multiple compounds simultaneously.
10. Peptide Vendor Quality Assessment: What Researchers Should Verify
The quality of research outcomes is inextricably linked to the purity and integrity of the compounds used. This PepGuide section addresses how researchers can systematically evaluate peptide vendors before making sourcing decisions.
The most important quality metric for any research peptide is purity, typically expressed as a percentage and verified through High Performance Liquid Chromatography (HPLC). Reputable vendors provide HPLC chromatograms for each batch, with research-grade compounds generally held to a purity threshold of 98% or higher. Mass spectrometry (MS) analysis is the complementary verification technique that confirms molecular identity: HPLC tells you how pure the sample is, while MS confirms that what you have is actually the compound you ordered. Vendors who provide both HPLC and MS certificates of analysis (CoA) for individual lots represent the standard of quality in responsible peptide supply.
Researchers should also evaluate vendor transparency regarding manufacturing origin, storage and shipping practices, and return or replacement policies for compromised product. Vials that arrive warm, improperly sealed, or visually turbid represent potential quality failures. The presence of endotoxin testing, also called Limulus Amebocyte Lysate (LAL) testing, in vendor CoA documentation is an additional quality indicator relevant for compounds intended for injectable research applications. Community reviews, independent third-party testing, and forums focused on research compound sourcing can supplement formal CoA review when evaluating a vendor for the first time.
11. Legal and Regulatory Landscape for Research Peptides
No complete peptide reference would be responsible without a thorough treatment of the legal and regulatory environment. The status of research peptides varies significantly by jurisdiction, compound class, and intended use, and researchers have an obligation to understand the framework that governs their work.
In the United States, research peptides occupy a nuanced legal space. Many peptides are not scheduled controlled substances and are not FDA-approved drugs, meaning their purchase and possession for legitimate research purposes is generally permissible. However, the FDA has taken enforcement action against companies that market research peptides with explicit claims about human use, therapeutic benefit, or that sell them as dietary supplements. The key regulatory distinction is between compounds sold strictly for in vitro and preclinical research use versus those being positioned as products for human consumption.
Some compounds covered in this PepGuide occupy more complex regulatory positions. Semaglutide, for example, is an FDA-approved drug (Ozempic, Wegovy), meaning that compounding pharmacies and research suppliers operate under distinct and sometimes overlapping frameworks when handling it. Researchers should consult jurisdiction-specific legal guidance and, where applicable, ensure that their work is conducted under appropriate institutional oversight such as an Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) approval.
Outside the United States, regulatory frameworks differ considerably. Some peptides freely available for research purchase in the US are prescription-only or scheduled substances in the UK, Australia, Canada, and EU member states. This peptide guide strongly recommends that all researchers verify the legal status of any compound in their specific country before procurement or use.
12. Longevity Peptides and Emerging Research Frontiers
The final frontier covered in this complete peptide reference is the emerging category of longevity-focused compounds. Epithalon (Epitalon) is a synthetic tetrapeptide derived from the natural pineal peptide Epithalamin. Its most studied mechanism involves telomerase activation, the enzyme responsible for maintaining telomere length. Telomere shortening is one of the hallmark processes of cellular aging, and compounds that can safely modulate telomerase activity represent a compelling area of geroscience research.
Thymalin and other thymic peptides are studied for their immunomodulatory properties and their potential role in restoring thymic function in aging research models. The thymus undergoes significant involution with age, contributing to immunosenescence, and peptides that can partially restore thymic output are of considerable interest in longevity research. GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide with roles in wound healing, anti-inflammatory signaling, and gene expression modulation. Its presence in plasma and its concentration changes with age have made it a focus of aging and tissue regeneration research.
Collectively,